Fluxergy's COVID-19 Test: Now Approved for CE-IVD
Fluxergy’s easy-to-use RT-qPCR test can detect SARS-CoV-2 in one hour.
Learn More
Challenging the Boundaries of Health Testing
Designed to quickly identify and measure cells, pathogens, molecules, and more.
Request More Information
Designed for Simplified Testing
A first-of-its-kind multimodal laboratory platform capable of detecting multiple analyte types.
Request More Information
Designed and Manufactured in Irvine, California
We proudly build our next-generation laboratory testing devices and consumables in the United States.
Request More Information
An Even Smaller Analyzer: Being Designed for Home Use
Our MK Mini prototype fits in the palm of your hands. Our goal is to make testing accessible for everyone.
Request More Information
Previous
Next

Fluxergy's One-Hour COVID-19 Test: Now Approved for CE-IVD

The Fluxergy Analyzer system, which utilizes state-of-the-art PCR and microfluidics technology, has been shown to accurately identify the SARS-CoV-2 virus in one hour*, with NO RNA extraction steps.

*Results were obtained from internal performance evaluation using clinical samples benchmarked against an FDA-EUA approved method.

Pipette COVID-19 Reagent into Fluxergy Test Card
1. Place Prepared Sample into Fluxergy Card
Insert COVID-19 Test Card into Fluxergy Analyzer
2. Insert Fluxergy Card into Fluxergy Analyzer
Using Fluxergy Works Software to View PCR Test Results on Laptop
3. Get PCR Results in One Hour

Fluxergy's three core technologies

PCR Fluxergy Card for Laboratory Testing

Fluxergy Card

Highly integrated & manufacturable single-use test cards for fast Sample-to-Answer testing.

Fluxergy Analyzer - MK13 Laboratory Testing Device

Fluxergy Analyzer 

A multisensor testing system designed to quickly detect molecules, chemicals, cells, and more.

Fluxergy Works PCR Curve Laboratory Testing Software

Fluxergy Works 

Our user interface capable of analyzing and disseminating data to users.

Multimodality: The Gamechanger in Point-of-Care

“The beauty of multimodality is the potential wealth of information provided to a healthcare provider, an amount of information typically reserved for 3 or 4 tests from different lab platforms. Our multimodal technology has the potential to consolidate a majority of critical lab tests to a single platform.”

Tej Patel, President and Co-Founder

Fluxergy TriCard Lower Resolution 4

PCR, Immunochemistry, and Chemistry Fluxergy Card Prototype

Multiple test Types on a single fluxergy card

Measuring multiple health and physiological parameters at once could enable more effective health testing, and we believe will enable better clinical outcomes.

Applications Across Industries

Fluxergy’s modular testing platform is built for use across industries and application types. Various sample types can be addressed with optical and electrical detection methods.

human
veterinary
food
environmental
forensics

Fluxergy System Across Market Verticals

Fluxergy’s modular testing platform is built for use across industries and application types. Various sample types can be addressed with optical and electrical detection methods.

human
food
environmental
forensics

What Experts Say about the Fluxergy Platform

Download Our White Paper: Multimodality’s Value as Shown by the COVID-19 Pandemic

By clicking submit, you agree to have the white paper sent to your email address provided and you agree to our Terms outlined in our Privacy and Cookie Policy.​

Designed to Scale

Testing isn’t as accessible as it should be. Fluxergy’s test cards are manufactured for high-volume scalability, using printed circuit board manufacturing technologies to reach millions of people.

Dual ISO 13485 and MDSAP Certification

These certifications demonstrate Fluxergy’s commitment to ensure compliance and effectiveness of its products and quality management system.

ISO 13485 Medical Device and MDSAP - Medical Device Single Audit Program

FEATURED IN

LATEST UPDATES

Why We Started (TBT): HIV Testing

Why HIV Testing is ImportantHIV Testing is critical to reducing its spread. The CDC recommends that all people ages 13-64 get tested at least once,

Equine Status Update

Here’s a link to Dr. Pusterla’s discussion about the benefits of having a biosecurity program at your practice, specifically for environmental monitoring of salmonella. This

Slow the Spread

How a Dual LFA and PCR COVID-19 Test Can Reduce Transmission RatesFluxergy already has a CE-IVD approved qPCR COVID-19 test on the market and is

Contact Us

By clicking submit, you agree to be contacted by Fluxergy and you agree to our Terms outlined in our Privacy and Cookie Policy.